Search Results
Previously Untreated FLT3-Mutated AML
Azacitidine, venetoclax and gilteritinib in previously untreated and R/R FLT3-mutated AML
Relapsed/Refractory FLT3-Mutated AML
Gilteritinib plus azacitidine versus azacitidine monotherapy for newly diagnosed FLT3-mutated AML
Dr. Levis on Gilteritinib in Relapsed/Refractory FLT3-Mutated AML
Novel treatment combinations for FLT3-mutated AML
Is gilteritinib the new breakthrough in the treatment of FLT3-mutated AML?
What are the future prospects for FLT3 mutated AML?
Sorafenib vs placebo in treatment-naïve FLT3-ITD AML
ADMIRAL: gilteritinib for R/R FLT3-mutated AML
Gilteritinib in the Treatment of FLT3-mutated AML
Initial report of the Beat AML umbrella study for previously untreated AML
